Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. The Circadian Clock Gene Bmal1 Regulates Microglial Pyroptosis After Spinal Cord Injury via NF-κB/MMP9

The Circadian Clock Gene Bmal1 Regulates Microglial Pyroptosis After Spinal Cord Injury via NF-κB/MMP9

CNS Neuroscience & Therapeutics, 2024 · DOI: https://doi.org/10.1111/cns.70130 · Published: October 17, 2024

Spinal Cord InjuryNeurologyGenetics

Simple Explanation

Spinal cord injury (SCI) often leads to neuroinflammation, where microglia cells in the spinal cord undergo pyroptosis, a form of cell death that worsens the injury. Bmal1, a gene involved in the body's internal clock, might play a role in regulating this process. This study found that Bmal1 can inhibit microglial pyroptosis after SCI by regulating the NF-κB /MMP9 pathway. This pathway involves proteins that control inflammation and tissue breakdown. The research suggests that targeting Bmal1 could be a new way to treat SCI by reducing neuroinflammation and promoting recovery.

Study Duration
28 Days
Participants
WT mice and Bmal1 KO female mice
Evidence Level
Not specified

Key Findings

  • 1
    Bmal1 inhibits NLRP3 inflammasome activation and microglial pyroptosis after SCI both in vitro and in vivo.
  • 2
    Bmal1 inhibits the release of IL-18 and IL-1β by inhibiting the NF-κB /MMP9 pathway.
  • 3
    NF-κB was identified as a transcription factor that promotes the expression of MMP9, which in turn regulates microglial pyroptosis after SCI.

Research Summary

This study investigates the role of Bmal1, a circadian clock gene, in regulating microglial pyroptosis after spinal cord injury (SCI). The results demonstrate that Bmal1 inhibits microglial pyroptosis and reduces secondary spinal cord injury by regulating the NF-κB/MMP9 pathway. The findings suggest that Bmal1 could be a promising therapeutic target for SCI treatment.

Practical Implications

Therapeutic Target

Bmal1 may be considered as a new target for the treatment of SCI.

Pathway Regulation

NF-κB/MMP9 signaling pathway is involved in regulating microglial pyroptosis after Bmal1-inhibited SCI in vivo.

Reduce Neuroinflammation

Bmal1 can alleviate spinal cord injury by reducing microglial pyroptosis.

Study Limitations

  • 1
    It remains uncertain whether Bmal1's impact extends to other metabolism-related signaling pathways within the central nervous system.
  • 2
    The more intricate regulatory connection between Bmal1 and NF-κB warrants further validation.
  • 3
    The effect of gender differences on recovery after SCI in mice has been neglected and needs to be improved in future studies.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury